SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI). - Paolisso P; Belmonte M; Gallinoro E; Scarsini R; Bergamaschi L; Portolan L; Armillotta M; Esposito G; Moscarella E; Benfari G; Montalto C; Shumkova M; et al. (Cardiovascular diabetology, 2024)